Does the media refer more to VANI or COCH?

In the previous week, Vivani Medical had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Vivani Medical and 1 mentions for Envoy Medical. Vivani Medical's average media sentiment score of 1.31 beat Envoy Medical's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vivani Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is RXST or COCH more profitable?

RxSight has a net margin of -36.58% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat RxSight's return on equity. Company Net Margins Return on Equity Return on Assets RxSight -36.58% -17.01% -15.12% Envoy Medical -9,875.64% N/A -177.92%

Does the media refer more to RXST or COCH?

In the previous week, RxSight and RxSight both had 1 articles in the media. RxSight's average media sentiment score of 0.00 equaled Envoy Medical'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RxSight 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, PDEX or COCH?

Pro-Dex has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $66.59M 3.04 $8.98M $3.62 17.51 Envoy Medical $240K 208.22 -$23.76M -$1.01 N/A

Is PDEX or COCH more profitable?

Pro-Dex has a net margin of 16.08% compared to Envoy Medical's net margin of -9,875.64%. Pro-Dex's return on equity of 22.78% beat Envoy Medical's return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 16.08% 22.78% 14.30% Envoy Medical -9,875.64% N/A -177.92%

Does the media refer more to PDEX or COCH?

In the previous week, Pro-Dex had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Pro-Dex and 1 mentions for Envoy Medical. Pro-Dex's average media sentiment score of 0.00 equaled Envoy Medical'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, EMBC or COCH?

Embecta has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Embecta $1.08B 0.17 $95.40M $1.90 1.65 Envoy Medical $240K 208.22 -$23.76M -$1.01 N/A

Is EMBC or COCH more profitable?

Embecta has a net margin of 10.73% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Embecta's return on equity. Company Net Margins Return on Equity Return on Assets Embecta 10.73% -23.96% 14.12% Envoy Medical -9,875.64% N/A -177.92%

Does the media refer more to EMBC or COCH?

In the previous week, Embecta had 27 more articles in the media than Envoy Medical. MarketBeat recorded 28 mentions for Embecta and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 0.00 beat Embecta's score of -0.16 indicating that Envoy Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Embecta 0 Very Positive mention(s) 1 Positive mention(s) 22 Neutral mention(s) 1 Negative mention(s) 4 Very Negative mention(s) Neutral Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, INFU or COCH?

InfuSystem has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InfuSystem $142.40M 1.29 $870K $0.38 23.89 Envoy Medical $240K 208.22 -$23.76M -$1.01 N/A

Does the media refer more to INFU or COCH?

In the previous week, InfuSystem and InfuSystem both had 1 articles in the media. InfuSystem's average media sentiment score of 1.95 beat Envoy Medical's score of 0.00 indicating that InfuSystem is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InfuSystem 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Envoy Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Envoy Medical (COCH) Competitors

$0.65 -0.01 (-1.54%)

As of 04:00 PM Eastern

Compare

COCH vs. VANI, RXST, PDEX, EMBC, and INFU

Should you buy Envoy Medical stock or one of its competitors? MarketBeat compares Envoy Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Envoy Medical include Vivani Medical (VANI), RxSight (RXST), Pro-Dex (PDEX), Embecta (EMBC), and InfuSystem (INFU). These companies are all part of the "medical equipment" industry.

How does Envoy Medical compare to Vivani Medical?

Vivani Medical (NASDAQ:VANI) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
Envoy Medical	-9,875.64%	N/A	-177.92%

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by company insiders. Comparatively, 7.1% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Vivani Medical has a beta of 2.31, suggesting that its stock price is 131% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

Vivani Medical currently has a consensus price target of $3.75, suggesting a potential upside of 215.13%. Envoy Medical has a consensus price target of $2.50, suggesting a potential upside of 284.62%. Given Envoy Medical's higher possible upside, analysts plainly believe Envoy Medical is more favorable than Vivani Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
Envoy Medical	$240K	208.22	-$23.76M	-$1.01	N/A

In the previous week, Vivani Medical had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Vivani Medical and 1 mentions for Envoy Medical. Vivani Medical's average media sentiment score of 1.31 beat Envoy Medical's score of 0.00 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vivani Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Vivani Medical beats Envoy Medical on 9 of the 15 factors compared between the two stocks.

How does Envoy Medical compare to RxSight?

RxSight (NASDAQ:RXST) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

RxSight has a net margin of -36.58% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat RxSight's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RxSight	-36.58%	-17.01%	-15.12%
Envoy Medical	-9,875.64%	N/A	-177.92%

RxSight has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

78.8% of RxSight shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 10.1% of RxSight shares are held by company insiders. Comparatively, 7.1% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Envoy Medical has lower revenue, but higher earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RxSight	$134.48M	1.61	-$38.94M	-$1.13	N/A
Envoy Medical	$240K	208.22	-$23.76M	-$1.01	N/A

In the previous week, RxSight and RxSight both had 1 articles in the media. RxSight's average media sentiment score of 0.00 equaled Envoy Medical'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RxSight	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

RxSight currently has a consensus price target of $9.44, suggesting a potential upside of 80.93%. Envoy Medical has a consensus price target of $2.50, suggesting a potential upside of 284.62%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than RxSight.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RxSight	3 Sell rating(s)	10 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.93
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Envoy Medical beats RxSight on 8 of the 14 factors compared between the two stocks.

How does Envoy Medical compare to Pro-Dex?

Pro-Dex (NASDAQ:PDEX) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by insiders. Comparatively, 7.1% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Pro-Dex has a beta of -0.02, meaning that its share price is 102% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

In the previous week, Pro-Dex had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Pro-Dex and 1 mentions for Envoy Medical. Pro-Dex's average media sentiment score of 0.00 equaled Envoy Medical'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pro-Dex	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pro-Dex presently has a consensus target price of $70.00, indicating a potential upside of 10.43%. Envoy Medical has a consensus target price of $2.50, indicating a potential upside of 284.62%. Given Envoy Medical's higher possible upside, analysts plainly believe Envoy Medical is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Pro-Dex has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$66.59M	3.04	$8.98M	$3.62	17.51
Envoy Medical	$240K	208.22	-$23.76M	-$1.01	N/A

Pro-Dex has a net margin of 16.08% compared to Envoy Medical's net margin of -9,875.64%. Pro-Dex's return on equity of 22.78% beat Envoy Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	16.08%	22.78%	14.30%
Envoy Medical	-9,875.64%	N/A	-177.92%

Summary

Pro-Dex beats Envoy Medical on 11 of the 14 factors compared between the two stocks.

How does Envoy Medical compare to Embecta?

Embecta (NASDAQ:EMBC) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

93.8% of Embecta shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 1.3% of Embecta shares are held by company insiders. Comparatively, 7.1% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Embecta has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

In the previous week, Embecta had 27 more articles in the media than Envoy Medical. MarketBeat recorded 28 mentions for Embecta and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 0.00 beat Embecta's score of -0.16 indicating that Envoy Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Embecta	0 Very Positive mention(s)	1 Positive mention(s)	22 Neutral mention(s)	1 Negative mention(s)	4 Very Negative mention(s)	Neutral
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Embecta currently has a consensus price target of $11.00, suggesting a potential upside of 251.44%. Envoy Medical has a consensus price target of $2.50, suggesting a potential upside of 284.62%. Given Envoy Medical's stronger consensus rating and higher possible upside, analysts clearly believe Envoy Medical is more favorable than Embecta.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Embecta	3 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.40
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Embecta has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Embecta, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Embecta	$1.08B	0.17	$95.40M	$1.90	1.65
Envoy Medical	$240K	208.22	-$23.76M	-$1.01	N/A

Embecta has a net margin of 10.73% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Embecta's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Embecta	10.73%	-23.96%	14.12%
Envoy Medical	-9,875.64%	N/A	-177.92%

Summary

Embecta and Envoy Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to InfuSystem?

InfuSystem (NYSE:INFU) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

71.1% of InfuSystem shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 10.8% of InfuSystem shares are held by company insiders. Comparatively, 7.1% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

InfuSystem has a net margin of 1.12% compared to Envoy Medical's net margin of -9,875.64%. InfuSystem's return on equity of 2.78% beat Envoy Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
Envoy Medical	-9,875.64%	N/A	-177.92%

InfuSystem has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$142.40M	1.29	$870K	$0.38	23.89
Envoy Medical	$240K	208.22	-$23.76M	-$1.01	N/A

InfuSystem has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market.

In the previous week, InfuSystem and InfuSystem both had 1 articles in the media. InfuSystem's average media sentiment score of 1.95 beat Envoy Medical's score of 0.00 indicating that InfuSystem is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InfuSystem	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Envoy Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

InfuSystem presently has a consensus target price of $15.00, suggesting a potential upside of 65.20%. Envoy Medical has a consensus target price of $2.50, suggesting a potential upside of 284.62%. Given Envoy Medical's higher possible upside, analysts plainly believe Envoy Medical is more favorable than InfuSystem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

InfuSystem beats Envoy Medical on 12 of the 15 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COCH vs. The Competition

Export

Metric	Envoy Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$50.76M	$7.05B	$6.45B	$12.39B
Dividend Yield	N/A	1.28%	2.69%	5.83%
P/E Ratio	-0.64	48.65	24.92	23.98
Price / Sales	208.22	76.50	528.51	109.04
Price / Cash	N/A	24.78	44.82	54.51
Price / Book	-1.55	7.13	10.79	6.50
Net Income	-$23.76M	$159.20M	$3.56B	$336.88M
7 Day Performance	0.25%	-1.41%	1.67%	-0.22%
1 Month Performance	-8.32%	-1.97%	0.43%	0.77%
1 Year Performance	-53.57%	7.94%	32.84%	31.57%

Envoy Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COCH Envoy Medical	2.0851 of 5 stars	$0.65 -1.5%	$2.50 +284.6%	-52.8%	$50.76M	$240K	N/A	34	News Coverage
VANI Vivani Medical	4.0259 of 5 stars	$1.16 -1.3%	$3.50 +203.0%	-10.3%	$99.61M	N/A	N/A	20	News Coverage Positive News Analyst Forecast
RXST RxSight	2.5244 of 5 stars	$4.66 -0.5%	$9.44 +102.9%	-63.6%	$192.76M	$134.48M	N/A	220	News Coverage
PDEX Pro-Dex	2.1206 of 5 stars	$60.20 -3.4%	$70.00 +16.3%	+58.9%	$192.02M	$66.59M	16.63	140
EMBC Embecta	4.0196 of 5 stars	$3.14 +1.5%	$11.00 +250.9%	-69.0%	$186M	$1.08B	1.65	1,850	Trending News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COCH) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envoy Medical (COCH) Competitors

COCH vs. VANI, RXST, PDEX, EMBC, and INFU

How does Envoy Medical compare to Vivani Medical?

Summary

How does Envoy Medical compare to RxSight?

Summary

How does Envoy Medical compare to Pro-Dex?

Summary

How does Envoy Medical compare to Embecta?

Summary

How does Envoy Medical compare to InfuSystem?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envoy Medical (COCH) Competitors

COCH vs. VANI, RXST, PDEX, EMBC, and INFU

How does Envoy Medical compare to Vivani Medical?

Is VANI or COCH more profitable?

Do institutionals and insiders have more ownership in VANI or COCH?

Which has more volatility and risk, VANI or COCH?

Do analysts recommend VANI or COCH?

Which has stronger earnings and valuation, VANI or COCH?

Does the media refer more to VANI or COCH?

Summary

How does Envoy Medical compare to RxSight?

Is RXST or COCH more profitable?

Which has more volatility and risk, RXST or COCH?

Do insiders & institutionals hold more shares of RXST or COCH?

Which has higher valuation and earnings, RXST or COCH?

Does the media refer more to RXST or COCH?

Do analysts rate RXST or COCH?

Summary

How does Envoy Medical compare to Pro-Dex?

Do insiders and institutionals hold more shares of PDEX or COCH?

Which has more risk and volatility, PDEX or COCH?

Does the media refer more to PDEX or COCH?

Do analysts prefer PDEX or COCH?

Which has higher valuation & earnings, PDEX or COCH?

Is PDEX or COCH more profitable?

Summary

How does Envoy Medical compare to Embecta?

Do institutionals & insiders believe in EMBC or COCH?

Which has more volatility and risk, EMBC or COCH?

Does the media refer more to EMBC or COCH?

Do analysts prefer EMBC or COCH?

Which has preferable earnings & valuation, EMBC or COCH?

Is EMBC or COCH more profitable?

Summary

How does Envoy Medical compare to InfuSystem?

Do institutionals and insiders hold more shares of INFU or COCH?

Is INFU or COCH more profitable?

Which has better earnings & valuation, INFU or COCH?

Which has more volatility & risk, INFU or COCH?

Does the media refer more to INFU or COCH?

Do analysts prefer INFU or COCH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools